4th Meeting of the EASDEC

EASD STUDY GROUP ON DIABETIC EYE COMPLICATIONS.



in Conjunction with the
2nd Meeting of the
IDF/WHO (SAINT VINCENT) WORKING GROUP
"PREVENTION OF DIABETES-RELATED BLINDNESS IN EUROPE".



PROGRAMME

Sunday, 25th September 1994.

EASDEC Session


08.30-08.45 - Opening.

08.45-10.15 - Free communications.

HIGH PREVALENCE OF UNRECOGNIZED VISUAL FIELD DEFECTS IN DIABETES. (C Giorda et al., Turin, Italy).

DIABETIC IRIDOPATHY IN PROLIFERATIVE DIABETIC RETINOPATHY. (J Tòth et al., Budapest, Hungary).

FOVEAL AVASCULAR ZONE IN DIABETES MELLITUS. (M Battaglia Parodi et al., Trieste, Italy).

SCOTOPIC THRESHOLD RESPONSE (STR) PATTERN IN NON RETINOPATHIC TYPE 2 DIABETIC PATIENTS. (E Rispoli et al., Rome, Italy).

EVOLUTION OF THE OSCILLATORY POTENTIALS OF THE ELECTRORETINOGRAM IN TYPE 1 DIABETES. A 10 YEAR STUDY. (F Ponte et al., Palermo, Italy).

ASSESSING THE RISK OF FAILURE TO ATTAIN DRIVING STANDARDS FOLLOWING LASER PHOTOCOAGULATION. (SW Mackie et al., Glasgow, UK).



10.15-10.45 - Keynote lecture: DIABETIC MICROANGIOPATHY: A PHYSIOLOGICAL PERSPECTIVE (JE Tooke, Exeter, UK).



10.45-11.15 - COFFEE BREAK


11.15-12.45 - Free communications.

PREVENTION OF BLINDNESS BY PANRETINAL PHOTOCOAGULATION AND EARLY VITRECTOMY IN FLORID DIABETIC RETINOPATHY. (C Favard et al., Paris, France).

RESULTS OF MACULAR GRID PHOTOCOAGULATION FOR PREVENTION OF VISUAL LOSS IN DIABETIC CYSTOID MACULAR EDEMA. (C Guyot-Argenton et al., Paris, France).

EFFECT OF AMINOGUANIDINE AND TOLRESTAT ON GLUCOSE-INDUCED TOXICITY IN PERICYTES. (PA Molinatti et al., London, UK).

HIGH GLUCOSE DOES NOT AFFECT GROWTH AND PROTEIN SYNTHESIS OF BOVINE RETINAL ENDOTHELIAL CELLS IN CULTURE. (C Galli et al., Florence-Rome, Italy).

MODULATION OF GLYCOLYSIS BY HIGH GLUCOSE IN CULTURED HUMAN ENDOTHELIAL CELLS. (E Beltramo et al, Turin, Italy).

LP(a) CONCENTRATION AND APO(a) ISOFORMS IN TYPE 2 DIABETIC PATIENTS WITH AND WITHOUT DIABETIC RETINOPATHY. (P Buscaglia et al., Pavia, Italy).


12.45-13.00 - Introducing amendments to the London Protocol. (M Porta)

13.00 - LUNCH



SCREENING FOR DIABETIC RETINOPATHY IN EUROPE:
4 YEARS SINCE THE LONDON PROTOCOLS.

15.00-15.40 - Keynote lecture: EPIDEMIOLOGICAL SURVEILLANCE OF DIABETES RELATED BLINDNESS IN EUROPE. (AK Sjφlie, Aarhus, Denmark).


15.40-16.00 - APPLICATION OF CAPTURE-RECAPTURE METHODS TO THE SURVEILLANCE OF DIABETIC EYE DISEASE. (G Bruno, Turin, Italy).


16.00-17.30 - Making screening work.

16.00-16.30 - SEE (SAVE EYES IN EUROPE): THE LONDON PROTOCOL IN SOFTWARE (Sivieri, Turin, Italy) (on-screen computer demonstration)

16.30-16.45 - COMPUTER ASSISTED EVALUATION OF SCREENING OUTCOME (Rovera, Turin, Italy) (on-screen computer demonstration)

16.45-17.00 - THE IRISH DIABETIC REGISTER: DEMONSTRATION OF THE CURRENT SOFTWARE AND REVIEW OF IT'S WORKING USING A SET GROUP OF DIABETICS DIAGNOSED AFTER THE AGE OF 70 YEARS (Cahill, Dublin) (on-screen computer demonstration, if possible).

17.00-17.15 - RECALL SYSTEM FOR SCREENING OF PATIENTS WITH DIABETIC RETINOPATHY. (J Volk et al., Marburg, Germany) (on-screen computer demonstration, if possible).

17.15-17.30 - FOLLOW-UP OF PATIENTS WITH DIABETIC RETINOPATHY BY MEANS OF COMPUTERIZED CASE REPORTS. (M Peduzzi, Modena, Italy) (on-screen computer demonstration).


17.30-18.00 - COFFEE BREAK


18.00-19.45 - Free Communications.

RETINOPATHY SCREENING IN A RURAL AREA. (MFS Flatman et al., Norwich, UK).

THE LIVERPOOL DIABETIC EYE STUDY-PRACTICAL ISSUES IN SETTING UP A SCREENING PROGRAMME. (DM Broadbent et al., Liverpool, UK).

THE IMPACT OF DIABETIC RETINOPATHY SCREENING ON THE RISK-PROFILE FOR SEVERE VISUAL LOSS IN PROLIFERATIVE DIABETIC RETINOPATHY. (Kalm H et al., Goteborg, Sweden).

THE BENEFIT OF EARLY DIAGNOSIS OF TREATABLE DIABETIC RETINOPATHY FOR THE FOUR-YEAR VISUAL OUTCOME IN DIABETES MELLITUS. (E Agardh et al., Lund, Sweden).

PERFORMING DIABETIC RETINOPATHY SCREENING AND MEASURING THE INCIDENCE OF BLINDNESS IN AN URBAN REGION. (LB Bäcklund et al., Stockholm, Sweden).

WHY DO DIABETIC PATIENTS GO BLIND TODAY? (LM Jenkins et al., Stoke Mandeville, UK).

WHY IS SERIOUS VISUAL LOSS OCCURRING IN DIABETIC PATIENTS IN THE 1990's? (SM Eames et al., Birmingham, UK).


19.45-20.15 - Discussing changes in the London Protocol. (Kohner, Porta)


21.00 - SOCIAL DINNER
Monday, 26th September 1994.


09.00-09.30 - Poster discussion - EASDEC:

1. CONTRIBUTION OF HYPERTENSION TO THE DEVELOPMENT OF DIABETIC RETINOPATHY: AN EPIDEMIOLOGICAL STUDY. (A Maltzeff et al., Rome, Italy).

2. DIABETIC RETINOPATHY EVOLUTION AFTER KIDNEY AND PANCREAS TRANSPLANTATION. (R Caldara et al, Milan, Italy).

3. CLINICAL AND METABOLIC CHARACTERISTICS OF DIABETES IN A COHORT OF TYPE 1 (INSULIN-DEPENDENT) PATIENTS (IDDM) WITH AND WITHOUT DIABETIC RETINOPATHY. (JA Arroyo et al., Barcelona, Spain).

4. INFLUENCE OF SERUM LIPID FRACTIONS ON THE COURSE OF DIABETIC MACULAR EDEMA AFTER PHOTOCOAGULATION. (G Kieselbach et al., Innsbruck, Austria).

5. PROFESSIONAL REHABILITATION OF PATIENTS WITH DIABETES MELLITUS. (E Moskalets, Moscow, Russia).


09.30-10.30 - Poster discussion - Screening.

6. COMPLIANCE AND COMMUNICATION IN SCREENING FOR DIABETIC RETINOPATHY. (H Kalm et al., Göteborg, Sweden)

7. HIGH PATIENT TURNOVER LIMITS EFFICANCY OF HOSPITAL CLINIC-BASED DIABETIC RETINOPATHY SCREENING. (JS Corcoran et al., London, UK).

8. WHAT'S GOING ON ABOUT THE MANAGEMENT OF DIABETIC EYE PROBLEMS IN A SPECIFIC AREA IN SWITZERLAND, THE CANTON DE VAUD? (N Ducrey, Lausanne, Switzerland).

9. COST-BENEFIT-ANALYSIS OF DIABETIC RETINOPATHY. (H Matz et al, Innsbruck, Austria).

10. DIABETIC RETINOPATHY AS A CAUSE OF BLINDNESS IN THE PROVINCE OF TURIN, NORTH-WESTERN ITALY, IN 1967-1991. (M Tomalino et al., Turin, Italy).

11. PROPOSAL OF SCHEME FOR DIABETIC RETINOPATHY. (M Mastrogiuseppe et al., Campobasso, Italy).

*12. "KEEPING AN EYE ON YOUR OWN DIABETIC FUNDUS": EFFECT OF POLAROID FUNDUS PHOTOGRAPHY ON PATIENT COMPLIANCE. (E Chantelau et al., Düsseldorf, Germany).

13. THE ROLE OF OPTOMETRISTS IN THE SCREENING FOR DIABETIC EYE DISEASE IN THE COMMUNITY. (T Barrie et al., Glasgow, Scotland, UK).

14. THE COMMUNITY DIABETIC EYE SCREENING PROJECT. (H Vinall et al., Birmingham, UK).

15. THE LIVERPOOL DIABETIC EYE STUDY - SENSITIVITY AND SPECIFICITY OF PHOTOGRAPHY AND DIRECT OPHTALMOSCOPY IN THE DETECTION OF SIGHT THREATENING EYE DISEASE. (SP Harding et al, Liverpool, UK).

16. NON-MYDRIATIC RETINAL CAMERAS ARE COMPARED WITH CONVENTIONAL RETINAL CAMERAS. RESULTS WILL BE PRESENTED. (BCP Polak et al., Nijmegen, The Netherlands).

17. SCREENING FOR DIABETIC RETINOPATHY WITH A MYDRIATIC 60° RETINAL CAMERA. (WJ Kalk et al., Johannesburg, South Africa).


10.30-11.00 - COFFEE BREAK


11.00.12.00 - Poster discussion - Screening.

18. RETINOPATHY SCREENING STUDY IN A JUVENILE DIABETIC CLINIC. (U Farrell et al., Cardiff, Wales, UK).

19. DISABILITY CAUSED BY EYE COMPLICATIONS IN PATIENTS WITH DIABETES MELLITUS IN RUSSIA. (E Moskalets et al., Moscow, Russia).

20. SCREENING OF DIABETIC OPTHALMOPATHIES IN UZBEKISTAN. (AR Khudaiberdiev, Tashkent, Republic of Uzbekistan).

21. A FREQUENCY STUDY OF DIABETIC RETINOPATHY IN PISA COUNTY. (R Miccoli et al., Pisa, Italy).

22. SCREENING OF DIABETIC RETINOPATHY IN A POPULATION OF 502 DIABETIC PATIENTS IN FLORENCE. (P Perri et al., Florence, Italy).

23. PREVALENCE AND RELATIONSHIP WITH RISK FACTOR OF DIABETIC RETINOPATHY IN AN OUTPATIENT POPULATION. (M Filipponi, Bergamo, Italy).

24. SCREENING FOR DIABETIC RETINOPATHY IN THE VUK VRHOVAC INSTITUTE IN ZAGREB. (Z Resman et al., Zagreb, Croatia).

25. PREVALENCE AND INCIDENCE OF DIABETIC RETINOPATHY IN A COHORT OF 712 TYPE I (INSULIN-DEPENDENT) DIABETIC PATIENTS (IDDM). (JA Arroyo, Barcelona, Spain).

26. THE PREVALENCE OF EYE DISEASE IN DIABETIC PATIENTS DIAGNOSED AFTER THE AGE OF 70 YEARS. (M Cahill et al., Dublin, Ireland).

27. A POPULATION BASED STUDY OF SCREENING METHODS FOR DIABETIC RETINOPATHY - THE WELSH COMMUNITY DIABETIC RETINOPATHY STUDY. (DR Owens et al, Cardiff, Wales, UK).

28. SCREENING FOR DIABETIC RETINOPATHY IN FINLAND: FOUR YEARS SINCE THE LONDON PROTOCOLS (P Summanen, Helsinki, Finland).

29. DIABETIC RETINOPATHY IN NON-INSULIN-DEPENDENT DIABETIC PATIENTS: RELATIONSHIP TO MICROALBUMINURIA (L Monge et al., Turin, Italy).


12.00-13.00 - Finalizing changes in the London Protocol (Porta, Kohner)


13.00. LUNCH AND FAREWELL.

 




CONTACT EASDEC »


W3C standards logos

site developed by Netsima Ltd »